
View larger version (38K):
[in a new window]
|
Fig. 3. Intact SMAD2/3 signaling is required for the maintenance of the
undifferentiated state in hESCs and the formation of embryoid bodies. (A)
Western blot analysis of H1 hESCs cultured in conditions in which SMAD2/3
signaling is intact or inhibited. Cells were cultured for 4 days in CM, in
nCM, in nCM supplemented with 2 µM BIO, in CM supplemented with 10 µM
SB431542, and in nCM supplemented with 2 µM BIO and 10 µM SB431542.
Membranes were probed with antibodies specific for phosphorylated (P) SMAD2,
SMAD2/3, phosphorylated SMAD1/5, SMAD1/5, OCT3/4 and -tubulin (as a
control for protein loading). (B) Expression analysis of H1 hESCs. Cells were
cultured for 4 days in nCM supplemented with 25 ng/ml activin A, in CM
supplemented with 25 ng/ml BMP4, in CM, in nCM, in nCM supplemented with 2
µM BIO in CM supplemented with 10 µM SB431542, and in nCM supplemented
with 2 µM BIO and 10 µM SB431542. RT-PCR was performed on these cells
using primers for human OCT3/4, nanog, ß-actin (as a loading control) and
ß-actin RT minus (as a control for contamination with genomic DNA). (C)
Western blot analysis of H1 hESCs cultured in the presence of a cocktail of
soluble receptors specific to the activin/nodal pathway. Cells were cultured
for 5 days in CM, in nCM, in CM supplemented with 10 µM SB431542, and in CM
supplemented with hrActRIB (5 µg/ml), hrActRIIB (5 µg/ml) and hrCripto
(250 ng/ml). Membranes were probed with antibodies specific for phosphorylated
SMAD2, OCT3/4, NANOG and -tubulin (as a control for protein loading).
(D) Histogram describing number of embryoid bodies formed from BGN2 hESCs.
Cells were cultured for 7 days in CM, in nCM, in nCM with 25 ng/ml activin A,
in CM with 10 µM SB431542, in nCM with 2 µM BIO, and in nCM with 2 µM
BIO and 10 µM SB431542. Cells were then detached from substrate and
cultured in a suspension of nCM for 7 more days. Histograms and error bars
(s.e.m.) represent the experiment performed in triplicate and on two separate
passages of BGN2 cells.
|